Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pulsed introduction of low-dose RANKL as a therapy for atherosclerosis

Pulsed introduction of low-dose RANKL as a therapy for atherosclerosis

US Patent 10328123 · Granted Jun 25, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Protective helmet2025
Pulsed introduction of low-dose RANKL as a therapy for diet-induced atherosclero2020
Pulsed introduction of low-dose RANKL as a therapy for diet-induced atherosclero2020
Pulsed introduction of low-dose RANKL as a therapy for diet-induced atherosclero2020
Pulsed introduction of low-dose RANKL as a therapy for osteogenesis imperfecta2018
Suppression of bone loss by introducing FoxP3+ CD8 T-cells (TcREG)2017
Suppression of bone loss by introducing FoxP3+ CD8 T-cells (TcREG)2015
Sequence covariance networks, methods and uses therefor2014
Reversible association of nucleic acid with a carboxylated substrate2006
Human methionine aminopeptidase type 32005
Methionine aminopeptidase type 32003
Cytokine family member EF-72001